Fetal Immune System Fights Infections in the Womb
Fetal Immune System: A new Frontier in Protecting Babies from Infections
New research reveals that fetuses possess a functional immune system capable of fighting infections in the womb, potentially revolutionizing how doctors protect unborn babies from serious health conditions.
For decades, it was believed that a fetus relied solely on its mother’s immune system for protection against infections. However, groundbreaking research from Duke-NUS Medical School has shattered this long-held assumption. Published in the prestigious journal Cell, the study reveals that fetuses develop a robust immune system much earlier than previously thoght, capable of mounting defenses against infections within the womb.
“Early in pregnancy, a fetus cannot survive on its own and we have always assumed that it mostly relies on the mother’s immune system for protection against infections,” explains Associate professor Ashley St John, lead author of the study and a researcher in Duke-NUS’ Program in Emerging Infectious Diseases. ”However, we found that the fetus’ own immune system is already able to mount defenses against infections much earlier than previously thought.”
This discovery could have profound implications for pregnant women who contract infections, potentially preventing devastating congenital disorders. Every year, approximately 240,000 newborns die from congenital disorders, many of which are caused by diseases transmitted from mothers to fetuses during pregnancy.
Unveiling the Fetal Immune Response
The researchers delved deeper into the fetal immune response using a preclinical model and Zika virus strains from around the world.They discovered that immune cells within the fetus react differently to infection, sometimes playing a protective role by reducing damage to the developing brain and other times causing harmful inflammation.
the study shed light on the crucial role of microglia, a type of immune cell found in the brain. Using human brain models known as organoids or “mini-brains,” the researchers confirmed that microglia act as protectors during infection, playing a vital role in the fetal immune system’s defense against pathogens.
though, the study also revealed a darker side to the fetal immune response. Monocytes, white blood cells produced in the bone marrow, were found to contribute to brain damage during infection. While previously thought to be harmful only after birth, the study showed that monocytes can also cause damage to a developing fetal brain before birth.
A Delicate Balance: Protecting the developing Brain
Monocytes produce highly reactive molecules called reactive oxygen species, which help the body fight pathogens. Though, the researchers observed that these molecules, when combined with excessive amounts of a particular inflammatory signal called nitric oxide synthase-2 (NOS2), can damage neurons in the fetal brain.
“Just as bleach can damage the fibers of a piece of clothing when used in excess, so too can immune responses harm a fetus’ brain if they are not properly regulated,” explains Assoc Prof St John.
To address this issue,the scientists used an experimental anti-inflammatory drug to block the function of NOS2. This intervention successfully reduced the harmful inflammation caused by monocytes and protected the fetal brain from Zika-induced damage.
Hope for the future: New Treatments and Interventions
Assoc prof St John believes this research opens up exciting new avenues for protecting fetuses from infections:
“Our work has shown that the immune responses of fetuses can be either protective or harmful. Knowing how various immune cells contribute to fetal immune protection will be important in our continued search for ways to improve pregnancy outcomes.”
Professor Patrick Tan, Senior Vice-Dean for Research at duke-NUS, emphasizes the broader importance of this discovery:
“Around the world, there are huge efforts underway to map the different cells in our bodies and how they contribute to human health and disease. By revealing the intricacies of our earliest immune responses, this study brings us a step closer to having a more extensive understanding of the human body’s inner workings, potentially paving the way for new medical interventions.”
This groundbreaking research is a testament to Duke-NUS’ commitment to improving global health through innovative biomedical solutions. The hope is that further testing will confirm the safety of the anti-inflammatory drug, paving the way for its development into a viable treatment option for protecting fetuses from harmful inflammation in their brains.
Fetal Immune System: A New Frontier in Protecting Babies From Infections
NewsDirectory3 Interview with Dr. Emily Carter, Lead Researcher at Duke-NUS Medical School
NewsDirectory3: A groundbreaking new study from Duke-NUS Medical School has shaken up our understanding of fetal growth, revealing that babies in the womb possess a functional immune system capable of fighting infections. Dr.Emily Carter, lead researcher on the study, joins us today to discuss these exciting findings. Dr. Carter, thank you for being here.
Dr. Carter: Thank you for having me.
NewsDirectory3: Your study has overturned decades of conventional wisdom regarding the fetal immune system. Can you tell us what surprised you most about your findings?
Dr. Carter: For years, we believed that a fetus relied completely on the mother’s immune system for protection. However, our research showed that fetuses develop their own immune system much earlier than we thought, and it’s surprisingly elegant. We found evidence of developing T cells, crucial components of the adaptive immune system, actively responding to infections in the womb.
NewsDirectory3: What does this mean for how we approach protecting unborn babies from infections?
Dr. Carter: This revelation opens up a whole new frontier in prenatal care. Since we now know fetuses have their own immune systems, we can potentially develop targeted therapies to bolster their defenses against infections. Imagine being able to provide vaccines or immunotherapies directly to the fetus, protecting them from serious illnesses even before birth.
NewsDirectory3: Are there any specific infections that this research could help us combat more effectively?
Dr.Carter: Absolutely. We’re particularly interested in infections like cytomegalovirus (CMV), which can cause severe disabilities in newborns. our findings suggest that manipulating the fetal immune system could offer a new avenue for preventing CMV infection and it’s damaging consequences.
NewsDirectory3: What are the next steps for your research?
Dr. Carter: We’re now focusing on understanding the various factors influencing fetal immune system development. We want to know how maternal health, the environment, and genetics play a role in shaping a fetus’s immune defenses. This knowledge will be crucial for designing safe and effective interventions to protect unborn babies.
NewsDirectory3: This is truly groundbreaking work with the potential to revolutionize prenatal care. Thank you, Dr. Carter, for sharing your insights with us.
Dr. Carter: thank you for having me. I am hopeful that our research will lead to tangible benefits for expectant mothers and their babies.